leadf
logo-loader
viewFSD Pharma
(
CSE:HUGENASDAQ:HUGE
)

FSD Pharma says concerned shareholder group-backed nominees elected to board at annual meeting

The nominees of the concerned group, led by Anthony Durkacz and Zeeshan Saeed, were elected

Boardroom with three people
At a meeting of the board following the shareholder meeting, Durkacz and Saeed were appointed executive co-chairmen of the board

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9) announced that the slate of board of directors nominees brought forward by a group of concerned shareholders received the necessary votes at the company’s annual general and special meeting on May 14. 

The nominees of the concerned group, led by Anthony Durkacz and Zeeshan Saeed, were each elected, along with Frank Lavelle and Donal Carroll, to hold office for the ensuing year.  However, following his election, Lavelle resigned, the company said. Nitin Kaushal and Larry Latowsky are the board’s remaining two directors. 

“We are pleased to see that FSD shareholders have shown their overwhelming support for the concerned shareholders and the concerned shareholders’ nominees,” Durkacz and Saeed said in a statement. “We look forward to restoring FSD and know there is a lot of work ahead of us. We would like to thank all shareholders for their patience and support.” 

READ: FSD Pharma files New Animal Drug Application with FDA for FSD201 to treat gastrointestinal enteropathy in dogs

At a meeting of the board following the shareholder meeting, Durkacz and Saeed were appointed executive co-chairmen of the board.

Additionally, shareholders approved a special resolution to change the registered office of the company from Durham Region, Ontario to a location in Toronto.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: FSD Pharma

Follow
CSE:HUGE

Price: 1.98 CAD

Market Cap: $70.95 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

FSD Pharma 'excited' to acquire pharma group Lucid Psycheceuticals to...

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc (CSE:HUGE) (NASDAQ:HUGE) Interim CEO Anthony Durkacz tells Proactive the group is to buy Canada-based specialty psychedelic pharma group Lucid Psycheceuticals Inc in a stock deal worth around US$9 million (C$11.3 million). Durkacz says the life sciences...

3 weeks, 5 days ago

2 min read